Accéder au contenu
Merck

In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives.

Antimicrobial agents and chemotherapy (2008-07-16)
Martin Spicher, Carole Roethlisberger, Catharina Lany, Britta Stadelmann, Jennifer Keiser, Luis M Ortega-Mora, Bruno Gottstein, Andrew Hemphill
RÉSUMÉ

In vitro treatment of Echinococcus multilocularis and Echinococcus granulosus larval stages with the antimalarials dihydroartemisinin and artesunate (10 to 40 microM) exhibited promising results, while 6 weeks of in vivo treatment of mice infected with E. multilocularis metacestodes (200 mg/kg of body weight/day) had no effect. However, combination treatments of both drugs with albendazole led to a substantial but statistically not significant reduction in parasite weight compared to results with albendazole alone.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
Albendazole, analytical standard, ≥98%